Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation
Completed · Phase 2/Phase 3 · Has a placebo group
Conditions studied: COVID
In brief
Interventional, randomized, double-blind, placebo-controlled study encompassing 2 development phases (Phase 2 and Phase 3).
Key facts
- Study ID
- NCT04447469
- Run by
- Kiniksa Pharmaceuticals International, plc
- People needed
- 814
- Starts
- 2020-07-28
- Expected to finish
- 2022-01-14
- Last updated by the study team
- 2025-01-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UCLA Medical Center — Los Angeles, California, United States
- SHARP Health Care — San Diego, California, United States
- Affinity Health — Chicago, Illinois, United States
- Tulane University School of Medicine — New Orleans, Louisiana, United States
- Allina Health System — Minneapolis, Minnesota, United States
- Mercy Clinic Hospitalists — Springfield, Missouri, United States
- University of Cincinnati — Cincinnati, Ohio, United States
- Bryn Mawr Hospital — Bryn Mawr, Pennsylvania, United States
- University of Texas Health Sciences — Houston, Texas, United States
- Hospital Cardio Pulmonar — Salvador, Estado de Bahia, Brazil
- Hospital Luxemburgo - Associação Mário Penna — Belo Horizonte, Minas Gerais, Brazil
- CPCLIN - Centro de Pesquisas Clínicas — Natal, Rio Grande do Norte, Brazil
- Hospital Bruno Born — Lajeado, Rio Grande do Sul, Brazil
- UPECLIN - Unidade de Pesquisa Clínica — Botucatu, São Paulo, Brazil
- IPECC - Instituto de Pesquisa Clínica de Campinas — Campinas, São Paulo, Brazil
- Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo — Ribeirão Preto, São Paulo, Brazil
- Hospital Adventista de Belem — Belém, Brazil
- IEP HGF - Instituto de Estudos e Pesquisas Clinicas do Ceará — Fortaleza, Brazil
- Fundação Faculdade Regional de Medicina de São José do Rio Preto — São José, Brazil
- Hospital Alemão Oswaldo Cruz — São Paulo, Brazil
- Clinica Las Condes — Santiago, Chile
- Hospital Clinico Universidad de Chile — Santiago, Chile
- Hospital Nacional Alberto Sabogal Sologuren — Bellavista, Peru
- Essalud - Hospital de Emergencias Grau — Lima Cercado, Peru
- Hospital Nacional Cayetano Heredia — San Martín de Porres, Peru
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.